Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | SRC | P12931 | 2/20 | 0.43 |
| ▸ | ITGAV | P06756 | 4/20 | 0.41 |
| ▸ | ITGB5 | P18084 | 4/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL14956415 | 0.82 | HDAC1 (0.42) | ITGAVITGB5ITGB3HDAC1MGAM | |
| SCHEMBL1760609 | 0.77 | GAA (0.49) | GAASRCITGAVITGB5ITGB3 | |
| Hydrochloric Acid SCHEMBL1760503 | 0.77 | FOLH1 (0.43) | FOLH1 | |
| Hydrochloric Acid SCHEMBL1524151 | 0.77 | GAA (0.48) | GAASRCITGAVITGB5ITGB3 | |
| Hydrochloric Acid SCHEMBL16495323 | 0.76 | HDAC1 (0.41) | HDAC1 | |
| SCHEMBL12648752 | 0.74 | GAA (0.50) | GAASRCITGAVITGB5ITGB3 | |
| Hydrochloric Acid SCHEMBL1524029 | 0.73 | GAA (0.49) | GAASRCITGAVITGB5ITGB3 | |
| Hydrochloric Acid SCHEMBL1760322 | 0.73 | HDAC1 (0.45) | HDAC1 | |
| Hydrochloric Acid SCHEMBL14957071 | 0.73 | ALDH1A1 (0.52) | GAAFOLH1 | |
| Hydrochloric Acid SCHEMBL14956271 | 0.68 | VIP (0.35) | HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9145395-B2 | Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2015-09-29 | — | — | US | disclosed |
| US-20130129795-A1 | INHIBITION AND DISPERSION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-TRIAZOLE DERIVATIVES | UNIV NORTH CAROLINA STATE (US) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129795-A1 | INHIBITION AND DISPERSION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-TRIAZOLE DERIVATIVES | TFPI, O60361, TFPI2 | GAA 2039/4885SRC 1386/4885ITGAV 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.